A Novel and Rapid Platform to Generate Gram-level Antibodies for Diagnostic and Therapeutic Use

08-16-2022 Hao Tan, Ph.D. Head of Shanghai Cell Line and Virus Vector Development Department, GenScript

Learn More

Antibody drug discovery and development is a long and arduous journey. It starts with identifying new therapeutic antibodies to treat different diseases.

07-14-2022 Dr. Huifoon Tan, Regional Product Manager, GenScript

Learn More

The CHO expression system is the most frequently used non-human mammalian cell line for developing and generating biological therapeutics. The CHO system is favored for its resilience to variations in growth conditions and resistance to infections.

06-30-2022 Ishita Barman, Sr. Field Application Scientist, GenScript USA Inc.

Learn More

The origin and biology of SARS-CoV-2, the virus responsible for the COVID-19 pandemic will be discussed. More specifically, we will detail how our immune system responds to infection, how variants such as Omicron emerge, and we will delineate the differen

06-23-2022 Benjamin tenOever, Ph.D.Professor of Microbiology & Director of the Virus Research Institute, NYU

Learn More

Making Therapeutic Antibodies Simple, Fast and Safe

06-22-2022 Lidan Ding

Learn More

Protein interactions orchestrate cellular processes, but their analysis is challenging, especially in the native context. This webcast will explore the feasibility of deriving vital structural insights for protein communities in endogenous cellular extrac

06-16-2022 Prof. Panagiotis Kastritis

Learn More